Inhibition of isoprenaline-induced tachycardia in calves with the beta-receptor blockader carazolol
Gränzer, W.; Eichinger, H.
Berliner und Munchener Tierarztliche Wochenschrift 95(3): 47-49
1982
ISSN/ISBN: 0005-9366 PMID: 6121555 Document Number: 182897
Document emailed within 1 workday
Related Documents
Rudloff, P.R.; Bostedt, H. 1984: Effect of the beta blockader carazolol (Suacron) on parturition in sows Tierarztliche Praxis 12(4): 443-449Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
Linée, P.; Le Pollès, J.B.; Lacroix, P.; Pape, D.; Quiniou, P.; Van den Driessche, J. 1977: Effects of a beta-adrenolytic and a diuretic vis-à-vis hyper-reninemia induced by isoprenaline in anesthetized dogs. Value of beta blocking-diuretic interaction Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 171(1): 218-223
Ljubuncić, P.; Stojiljković, M.P.; Winterhalter-Jadrić, M.; Vidović, Z.; Mujić, F. 1992: Efficacy of pretreatment with adrenergic beta-receptor blockers in the prevention of cardiotoxic effects of isoprenaline in rats Vojnosanitetski Pregled 49(4): 297-304
Oriowo, M.A. 1998: Atypical beta-adrenoceptors mediate isoprenaline induced vasodilatation in the rabbit uterine vascular bed African Journal of Medicine and Medical Sciences 27(1-2): 123-127
Rabast, U.; Kasper, H.; Schönborn, J.; Knechtel, B. 1977: Blood glucose concentration and insulin activity in serum after administration of the beta receptor blockader nifenalol-HC1 (INPEA). Studies in metabolically healthy people and diabetics Therapie der Gegenwart 116(6): 1162-1174
Bartsch, W.; Sponer, G.; Dietmann, K.; Kohler, M. 1981: Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats Arzneimittel-Forschung 31(11): 1885-1888
Zhu, Z.; Rockwell, P.; Lu, D.; Kotanides, H.; Pytowski, B.; Hicklin, D.J.; Bohlen, P.; Witte, L. 1998: Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library Cancer Research 58(15): 3209-3214
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Schimke, I.; Haberland, A.; Will-Shahab, L.; Kuttner, I.; Papies, B. 1989: Free radical-induced damage of cardiac sarcolemma (SL) and activity loss of beta-receptor adenylate cyclase system (beta-RAS). A comparison of the time courses Biomedica Biochimica Acta 48(2-3): S69-S72
Andersson, K.E.; Ingemarsson, I. 1975: Inhibition of uterine activity by means of adrenergic beta receptor stimulators Lakartidningen 72(3): 138-141
Meister, W. 1983: A beta blockader for every postinfarct patient? Münchener Medizinische Wochenschrift 125(46): 1055-1056
Schmidt, E.; Bruch H-P 1978: 1st experiences with the alpha-receptor blockader phentolamine in achalasia Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 49(1): 22-24